Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM

NCT06255847 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Pomalidomide, cyclophosphamide combined with dexametha

Sponsor

Shanxi Bethune Hospital